Overexpression of cyclin D1 is associated with poor prognosis in extremity soft-tissue sarcomas

Clinical Cancer Research

Volumn 4, Issue 10, 1998, Pages 2377-2382

  Kim, Steve H ^a   Lewis, Jonathan J ^a   Brennan, Murray F ^a   Woodruff, James M ^a   Dudas, Maria ^a   Cordon Cardo, Carlos ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL CYCLE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE SARCOMA; TUMOR GROWTH; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYCLIN D1; HUMANS; MIDDLE AGED; PROGNOSIS; SARCOMA; SURVIVAL RATE;

EID: 0031784412     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cordon-Cardo, C. Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia. Am. J. Pathol., 147: 545-560, 1995.
2. Sherr, C. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1997.
3. Arnold, A., Kim, H., Gaz, R., Eddy, R., Fukushima, Y., Byers, M., Shows, T., and Kronenberg, H. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J. Clin. Invest., 83: 2034-2040, 1989.
4. Motokura, T., Bloom, T., Kim, H., Juppner, H., Ruderman, J., Kronenberg, H., and Arnold, A. A novel cyclin encoded by bc11-linked candidate oncogene. Nature (Lond.), 350: 512-515, 1991.
5. Hall, M., and Peters, G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res., 68: 67-108, 1996.
6. Wang, T., Cardiff, R., Zukerberg, L., Lees, E., Arnold, A., and Schmidt, E. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (Lond.), 369: 669-671, 1994.
7. Bortner, D., and Rosenberg, M. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol. Cell. Biol., 17: 453-459, 1997.
8. Keyomarsi, K., Conte, D., Toyofuku, W., and Fox, M. Deregulation of cyclin E in breast cancer. Oncogene. 11: 941-950, 1995.
9. Keyomarsi, K., O'Leary, N., Molnar, G., Lees, E., Fingert, H., and Pardee, A. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res., 54: 380-385, 1994.
10. Akama, Y., Yasui, W., Yokozaki, H., Kuniyasu, H., Kitahara, K., Ishikawa, T., and Tahara, E. Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn. J. Cancer Res., 86: 617-621, 1995.
11. Li, S., Shiozawa, T., Nakayama. K., Nikaido, T., and Fujii, S. Stepwise abnormality of sex hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma. Cancer (Phila.), 77: 321-329, 1996.
12. Courjal, F., Louason, G., Speiser, P., Katsaros, D., Zeillinger, R., and Theillet, C. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int. J. Cancer, 69: 247-253, 1996.
13. Bréchot, C. Oncogenic activation of cyclin A. Curr. Opin. Genet. Dev., 3: 11-18, 1993.
14. Mashal, R., Lester, S., Corless, C., Richie, J., Chandra, R., Propert, K., and Dutta, A. Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res., 56: 4159-4163, 1996.
15. Maelandsmo, G., Berner, J-M., Flørenes, V., Forus, A., Hovig, E., Fodstad, Ø., and Myklebost, O. Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas-relationship to amplification and mRNA levels of CDK4 and CCND1. Br. J. Cancer, 72: 393-398, 1995.
16. Lewis, J., and Brennan, M. Soft tissue sarcomas. Curr. Probl. Surg., 33: 817-880, 1996.
17. Cordon-Cardo, C., and Richon, V. Expression of the retinoblastoma protein is regulated in normal human tissues. Am. J. Pathol., 144: 500-510, 1994.
18. Metha, C., and Patel, N. A network algorithm for performing Fisher's exact test in rXc contingency tables. J. Am. Stat. Assoc., 78: 427-434, 1983.
19. Kaplan, E., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Statist., 53: 457-481, 1958.
20. Peto, R., and Peto, J. Asymptotically efficient rank invariant procedures. J. R. Stat. Soc. A. 135: 185-207, 1972.
21. Cox, D. Regression models and life tables. J. R. Stat. Assoc., 34: 187-220, 1972.
22. Bartkova, J., Lukas, J., Strauss, M., and Bartek, J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene, 10: 775-778, 1995.
23. Krek, W., Xu, G., and Livingston, D. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell. 83: 1149-1158, 1995.
24. Bortner, D., and Rosenberg, M. Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis. Cell Growth Differ., 6: 1579-1589, 1995.
25. Seshadri, R., Lee, C., Hui, R., McCaul, K., Horsfall, D., and Sutherland, R. Cyclin D1 amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. Clin. Cancer Res., 2: 1177-1184, 1996.
26. Gray-Bablin, J., Zalvide, J., Fox, M., Knickerbocker, C., DeCaprio, J., and Keyomarsi, K. Cyclin E, a redundant cyclin in breast cancer. Proc. Natl. Acad. Sci. USA, 93: 15215-15220, 1996.